Komal Ramani1, Aaron E Robinson2,3, Joshua Berlind4, Wei Fan1, Aushinie Abeynayake1, Aleksandra Binek3, Lucía Barbier-Torres1, Mazen Noureddin1,5, Nicholas N Nissen5,6, Zehra Yildirim7, Ebru Erbay7, José M Mato8, Jennifer E Van Eyk3, Shelly C Lu1. 1. Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA. 2. Department of Genetics, Stanford University School of Medicine, Stanford, California, USA. 3. Smidt Heart Institute and Advanced Clinical Biosystems Research Institute, Los Angeles, California, USA. 4. Stem Cell Biology and Regenerative Medicine, University of Southern California, Los Angeles, California, USA. 5. Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, California, USA. 6. Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA. 7. Department of Cardiology, Department of Biomedical Sciences and Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. 8. Centers for Cooperative Research in Biosciences, CIC bioGUNETechnology Park of Bizkaia, Derio, Spain.
Abstract
BACKGROUND AND AIMS: Methionine adenosyltransferase 1A (MAT1A) is responsible for S-adenosylmethionine (SAMe) biosynthesis in the liver. Mice lacking Mat1a have hepatic SAMe depletion and develop NASH and HCC spontaneously. Several kinases are activated in Mat1a knockout (KO) mice livers. However, characterizing the phospho-proteome and determining whether they contribute to liver pathology remain open for study. Our study aimed to provide this knowledge. APPROACH AND RESULTS: We performed phospho-proteomics in Mat1a KO mice livers with and without SAMe treatment to identify SAMe-dependent changes that may contribute to liver pathology. Our studies used Mat1a KO mice at different ages treated with and without SAMe, cell lines, in vitro translation and kinase assays, and human liver specimens. We found that the most striking change was hyperphosphorylation and increased content of La-related protein 1 (LARP1), which, in the unphosphorylated form, negatively regulates translation of 5'-terminal oligopyrimidine (TOP)-containing mRNAs. Consistently, multiple TOP proteins are induced in KO livers. Translation of TOP mRNAs ribosomal protein S3 and ribosomal protein L18 was enhanced by LARP1 overexpression in liver cancer cells. We identified LARP1-T449 as a SAMe-sensitive phospho-site of cyclin-dependent kinase 2 (CDK2). Knocking down CDK2 lowered LARP1 phosphorylation and prevented LARP1-overexpression-mediated increase in translation. LARP1-T449 phosphorylation induced global translation, cell growth, migration, invasion, and expression of oncogenic TOP-ribosomal proteins in HCC cells. LARP1 expression is increased in human NASH and HCC. CONCLUSIONS: Our results reveal a SAMe-sensitive mechanism of LARP1 phosphorylation that may be involved in the progression of NASH to HCC.
BACKGROUND AND AIMS: Methionine adenosyltransferase 1A (MAT1A) is responsible for S-adenosylmethionine (SAMe) biosynthesis in the liver. Mice lacking Mat1a have hepatic SAMe depletion and develop NASH and HCC spontaneously. Several kinases are activated in Mat1a knockout (KO) mice livers. However, characterizing the phospho-proteome and determining whether they contribute to liver pathology remain open for study. Our study aimed to provide this knowledge. APPROACH AND RESULTS: We performed phospho-proteomics in Mat1a KO mice livers with and without SAMe treatment to identify SAMe-dependent changes that may contribute to liver pathology. Our studies used Mat1a KO mice at different ages treated with and without SAMe, cell lines, in vitro translation and kinase assays, and human liver specimens. We found that the most striking change was hyperphosphorylation and increased content of La-related protein 1 (LARP1), which, in the unphosphorylated form, negatively regulates translation of 5'-terminal oligopyrimidine (TOP)-containing mRNAs. Consistently, multiple TOP proteins are induced in KO livers. Translation of TOP mRNAs ribosomal protein S3 and ribosomal protein L18 was enhanced by LARP1 overexpression in liver cancer cells. We identified LARP1-T449 as a SAMe-sensitive phospho-site of cyclin-dependent kinase 2 (CDK2). Knocking down CDK2 lowered LARP1 phosphorylation and prevented LARP1-overexpression-mediated increase in translation. LARP1-T449 phosphorylation induced global translation, cell growth, migration, invasion, and expression of oncogenic TOP-ribosomal proteins in HCC cells. LARP1 expression is increased in human NASH and HCC. CONCLUSIONS: Our results reveal a SAMe-sensitive mechanism of LARP1 phosphorylation that may be involved in the progression of NASH to HCC.
Authors: Susan K Murphy; Hyuna Yang; Cynthia A Moylan; Herbert Pang; Andrew Dellinger; Manal F Abdelmalek; Melanie E Garrett; Allison Ashley-Koch; Ayako Suzuki; Hans L Tillmann; Michael A Hauser; Anna Mae Diehl Journal: Gastroenterology Date: 2013-07-31 Impact factor: 22.682
Authors: Roland Sonntag; Nives Giebeler; Yulia A Nevzorova; Jörg-Martin Bangen; Dirk Fahrenkamp; Daniela Lambertz; Ute Haas; Wei Hu; Nikolaus Gassler; Francisco Javier Cubero; Gerhard Müller-Newen; Ali T Abdallah; Ralf Weiskirchen; Fabio Ticconi; Ivan G Costa; Mariano Barbacid; Christian Trautwein; Christian Liedtke Journal: Proc Natl Acad Sci U S A Date: 2018-08-27 Impact factor: 11.205
Authors: Aaron E Robinson; Aleksandra Binek; Vidya Venkatraman; Brian C Searle; Ronald J Holewinski; George Rosenberger; Sarah J Parker; Nathan Basisty; Xueshu Xie; Peder J Lund; Gautam Saxena; José M Mato; Benjamin A Garcia; Birgit Schilling; Shelly C Lu; Jennifer E Van Eyk Journal: J Proteome Res Date: 2020-09-23 Impact factor: 4.466
Authors: Monika Waldherr; Miroslav Mišík; Franziska Ferk; Jana Tomc; Bojana Žegura; Metka Filipič; Wolfgang Mikulits; Sören Mai; Oskar Haas; Wolfgang W Huber; Elisabeth Haslinger; Siegfried Knasmüller Journal: Arch Toxicol Date: 2017-12-07 Impact factor: 5.153